Corcept Therapeutics
CORT
CORT
420 hedge funds and large institutions have $6.41B invested in Corcept Therapeutics in 2025 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 145 increasing their positions, 151 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
4% less repeat investments, than reductions
Existing positions increased: 145 | Existing positions reduced: 151
1.3% less ownership
Funds ownership: 74.54% → 73.24% (-1.3%)
Holders
420
Holding in Top 10
6
Calls
$74.4M
Puts
$62.4M
Top Buyers
| 1 | +$106M | |
| 2 | +$70.2M | |
| 3 | +$48.8M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$36.8M |
| 5 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$32M |
Top Sellers
| 1 | -$45.1M | |
| 2 | -$40.1M | |
| 3 | -$37.5M | |
| 4 |
Morgan Stanley
New York
|
-$35.5M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$34.9M |
